Sustained delivery of a HIF-1 antagonist for ocular neovascularization-Reference-Cited by-同舟云学术

Sustained delivery of a HIF-1 antagonist for ocular neovascularization

Published:2013-12 Issue:3 Volume:172 Page:625-633
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Iwase Takeshi,Fu Jie,Yoshida Tsunehiko,Muramatsu Daisuke,Miki Akiko,Hashida Noriyasu,Lu Lili,Oveson Brian,Lima e Silva Raquel,Seidel Christopher,Yang Ming,Connelly Sheila,Shen Jikui,Han Bing,Wu Mingsheng,Semenza Gregg L.,Hanes Justin,Campochiaro Peter A.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer;Yang;N. Engl. J. Med.,2003

2. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer;Hurwitz;N. Engl. J. Med.,2004

3. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N. Engl. J. Med.,2006

4. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis;Shih;Cancer Res.,2004

5. Photoreceptor-specific expression of PDGF-B results in traction retinal detachment;Seo;Am. J. Pathol.,2000

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modern Approach to Diabetic Retinopathy Diagnostics;Diagnostics;2024-08-24

2. Fostering the unleashing potential of nanocarriers-mediated delivery of ocular therapeutics;International Journal of Pharmaceutics;2024-06

3. Doxorubicin-loaded DNA origami nanostructures: stability in vitreous and their uptake and toxicity in ocular cells;Nanoscale;2024

4. Treatments for diabetic retinopathy and diabetic macular edema in pipeline;Therapeutic Targets for Diabetic Retinopathy;2024

5. Applications of nanomaterials in anti‐VEGF treatment for ophthalmic diseases;Journal of Biomedical Materials Research Part A;2023-10-18